The Valley Desk

NCT01911273 · Interventional trial

A Study To Evaluate The Efficacy And Safety of The Investigational Drug PF-03446962 (A Monoclonal Antibody With Antiangiogenic Features) In Combination With Best Supportive Care Versus Placebo Plus Best Supportive Care In Patients Affected By Recurrent Liver Cancer

Overall registry status Terminated

Phase 2

Conditions Carcinoma, Hepatocellular

Delaware Valley sites

First posted

Registry updated

Added to the directory

View this study on ClinicalTrials.gov